Multi‐omics predictive model based on clinical, radiomic and genomic features for predicting the response of limited‐stage small cell lung cancer to definitive chemoradiotherapy

Author:

Li Li1,Duan Jinghao1,Gao Yongsheng2,Yin Ying3,Yang Fengchang4,Tang Wenjie1,Song Xiaoyu1,Hu Tao1,Cui Jinfeng1,Yu Jinming1,Yuan Shuanghu15ORCID

Affiliation:

1. Department of Radiation Oncology Shandong Cancer Hospital and Institute Shandong First Medical University and Shandong Academy of Medical Sciences Jinan Shandong China

2. Department of Pathology Shandong Cancer Hospital and Institute Shandong First Medical University and Shandong Academy of Medical Sciences Jinan Shandong China

3. Department of Oncology Second People's Hospital of Yibin City Yibin Sichuan China

4. Department of Radiology Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences Jinan Shandong China

5. Department of Radiation Oncology The Affiliated Cancer Hospital of Zhengzhou University Henan China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Reference10 articles.

1. Lung Cancer‐Small Cell: Statistics 2021 Cancer.Net

2. Small cell lung cancer: a slightly less orphan disease after immunotherapy

3. Platinum versus non‐platinum chemotherapy regimens for small cell lung cancer;Amarasena IU;Cochrane Database Syst Rev,2015

4. Meningiomas

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3